Imperial, California - Most people who have the flu (influenza) have a mild illness and don't need to see a doctor. Common flu signs and symptoms include:

Jacksonville, Florida - A marker of immune function that predicts for better outcomes in patients treated with chemotherapy for triple negative breast cancer is also linked to improved prognosis in patients treated with chemotherapy for HER2-positive breast cancer. But that marker - the quantity of tumor-infiltrating lymphocytes (S-TILs) in a biopsy - appears irrelevant when trastuzumab is used.

San Francisco, California - Self-reported quality of life among patients diagnosed with aggressive lymphoma can predict overall survival and event-free survival, a Mayo Clinic study has found. The results were presented at the 56th American Society of Hematology annual meeting, in San Francisco.

Washington, DC - Forty states have enacted laws prohibiting the sale of electronic nicotine delivery systems (ENDS), including e-cigarettes, to minors, but 10 states and the District of Columbia still permit such sales, according to a report published by the Centers for Disease Control and Prevention in today’s Morbidity and Mortality Weekly Report (MMWR).

Mukwonago, Wisconsin - Sherrie Palm, author of the award-winning book "Pelvic Organ Prolapse: The Silent Epidemic", and the founder/executive director of APOPS, Association for Pelvic Organ Prolapse Support, a U.S.-based 501c3 nonprofit with international arms, is requesting contributions of any size to fund STIGMA*STRIDE Pennies for POP campaign.

Washington, DC - The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II). This test is intended for use as an additional, more specific test for human serum or plasma specimens that have previously tested positive on an FDA-licensed HTLV-I/II blood donor screening test. The MP Diagnostics HTLV Blot 2.4 is a qualitative enzyme immunoassay test intended to confirm infection with HTLV and to differentiate between HTLV-I and HTLV-II.